LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 47 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,918,360 | +26.2% | 16,941,357 | 0.0% | 1.47% | +30.2% |
Q2 2023 | $53,026,447 | -30.9% | 16,941,357 | 0.0% | 1.13% | -33.8% |
Q1 2023 | $76,744,347 | +9.7% | 16,941,357 | 0.0% | 1.71% | +18.2% |
Q4 2022 | $69,967,804 | +29.1% | 16,941,357 | 0.0% | 1.45% | +34.2% |
Q3 2022 | $54,212,000 | +374.4% | 16,941,357 | +190.6% | 1.08% | +357.2% |
Q2 2022 | $11,427,000 | -51.6% | 5,830,249 | 0.0% | 0.24% | -55.3% |
Q1 2022 | $23,613,000 | -62.5% | 5,830,249 | 0.0% | 0.53% | -60.0% |
Q4 2021 | $62,908,000 | -6.4% | 5,830,249 | 0.0% | 1.32% | +0.5% |
Q3 2021 | $67,223,000 | +17.4% | 5,830,249 | 0.0% | 1.31% | +29.0% |
Q2 2021 | $57,253,000 | -23.8% | 5,830,249 | +13.3% | 1.02% | -35.6% |
Q1 2021 | $75,162,000 | -31.8% | 5,144,539 | 0.0% | 1.58% | -27.4% |
Q4 2020 | $110,145,000 | +41.1% | 5,144,539 | 0.0% | 2.18% | +14.6% |
Q3 2020 | $78,043,000 | +18.1% | 5,144,539 | 0.0% | 1.90% | -1.3% |
Q2 2020 | $66,107,000 | – | 5,144,539 | – | 1.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,515,148 | $32,439,000 | 9.14% |
ACUTA CAPITAL PARTNERS, LLC | 863,100 | $18,479,000 | 5.03% |
SILVERARC CAPITAL MANAGEMENT, LLC | 217,203 | $4,650,000 | 2.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,144,539 | $110,145,000 | 2.18% |
Atlas Venture Advisors, Inc. | 292,184 | $6,256,000 | 1.40% |
Logos Global Management LP | 715,000 | $15,308,000 | 1.31% |
Sio Capital Management, LLC | 188,661 | $4,039,000 | 0.83% |
Vivo Capital, LLC | 799,662 | $17,121,000 | 0.76% |
Altium Capital Management LP | 93,261 | $1,997,000 | 0.75% |
RA Capital Management | 1,515,151 | $32,439,000 | 0.45% |